Literature DB >> 21499918

Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors.

Brit Neuhaus1, Sebastian Bühren, Barbara Böck, Frauke Alves, Wolfgang F Vogel, Friedemann Kiefer.   

Abstract

The non-receptor tyrosine kinase Syk is a well-characterized hematopoietic signal transducer, which is also expressed in non-hematopoietic cells. In epithelial cells, the function of Syk is not wholly known. It interacts with the receptor tyrosine kinase DDR1 and is frequently lost from metastatic mammary tumors. Here, using genetic tracing, we demonstrate Syk expression in murine mammary epithelium, myoepithelium and skin epithelium, but not in intestinal or lung epithelia. Investigating possible functions of Syk, we found a substantial suppression of cell mobility that depended on Syk kinase activity in trans-well migration and wounding assays. Co-expression of DDR1 resulted in constitutive interaction and strong activation of Syk kinase. Most importantly, Syk-mediated migration inhibition was blocked in the presence of DDR1, while conversely DDR1 knockdown restored migration inhibition. Our study identifies Syk as a potent inhibitor of epithelial migration and describes a first functional consequence of the interaction with the collagen receptor DDR1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499918     DOI: 10.1007/s00018-011-0676-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  46 in total

1.  Identification of two novel, kinase-deficient variants of discoidin domain receptor 1: differential expression in human colon cancer cell lines.

Authors:  F Alves; S Saupe; M Ledwon; F Schaub; W Hiddemann; W F Vogel
Journal:  FASEB J       Date:  2001-05       Impact factor: 5.191

2.  A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival.

Authors:  Anurag Singh; Patricia Greninger; Daniel Rhodes; Louise Koopman; Sheila Violette; Nabeel Bardeesy; Jeff Settleman
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

3.  Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.

Authors:  Ganapati H Mahabeleshwar; Gopal C Kundu
Journal:  J Biol Chem       Date:  2002-12-10       Impact factor: 5.157

4.  The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells.

Authors:  P J Coopman; M T Do; M Barth; E T Bowden; A J Hayes; E Basyuk; J K Blancato; P R Vezza; S W McLeskey; P H Mangeat; S C Mueller
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

5.  Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues.

Authors:  E Di Marco; N Cutuli; L Guerra; R Cancedda; M De Luca
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

6.  Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer.

Authors:  Tatsuya Toyama; Hirotaka Iwase; Hiroko Yamashita; Yasuo Hara; Yoko Omoto; Hiroshi Sugiura; Zhenhuan Zhang; Yoshitaka Fujii
Journal:  Cancer Lett       Date:  2003-01-10       Impact factor: 8.679

7.  Phosphoproteomic analysis of Syk kinase signaling in human cancer cells reveals its role in cell-cell adhesion.

Authors:  R M Larive; S Urbach; J Poncet; P Jouin; G Mascré; A Sahuquet; P H Mangeat; P J Coopman; N Bettache
Journal:  Oncogene       Date:  2009-05-04       Impact factor: 9.867

8.  Role of the protein tyrosine kinase Syk in regulating cell-cell adhesion and motility in breast cancer cells.

Authors:  Xiaoying Zhang; Ulka Shrikhande; Bethany M Alicie; Qing Zhou; Robert L Geahlen
Journal:  Mol Cancer Res       Date:  2009-05-12       Impact factor: 5.852

9.  Molecular characterization of the murine syk protein tyrosine kinase cDNA, transcripts and protein.

Authors:  M Flück; G Zürcher; A C Andres; A Ziemiecki
Journal:  Biochem Biophys Res Commun       Date:  1995-08-04       Impact factor: 3.575

10.  Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2.

Authors:  Osamu Inoue; Katsue Suzuki-Inoue; William L Dean; Jon Frampton; Steve P Watson
Journal:  J Cell Biol       Date:  2003-03-03       Impact factor: 10.539

View more
  14 in total

Review 1.  Discoidin domain receptor tyrosine kinases: new players in cancer progression.

Authors:  Rajeshwari R Valiathan; Marta Marco; Birgit Leitinger; Celina G Kleer; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

2.  Discoidin domain receptor 1 protein is a novel modulator of megakaryocyte-collagen interactions.

Authors:  Vittorio Abbonante; Cristian Gruppi; Diana Rubel; Oliver Gross; Remigio Moratti; Alessandra Balduini
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

3.  Discoidin domain receptor 1: New star in cancer-targeted therapy and its complex role in breast carcinoma.

Authors:  Hui Jing; Jingyuan Song; Junnian Zheng
Journal:  Oncol Lett       Date:  2018-01-15       Impact factor: 2.967

4.  SYK interaction with ITGβ4 suppressed by Epstein-Barr virus LMP2A modulates migration and invasion of nasopharyngeal carcinoma cells.

Authors:  X Zhou; L Matskova; L-S Z Rathje; X Xiao; G Gish; M Werner; I Ignatyev; N Yu; W Zhao; F Tian; B Hou; Z Zhang; T Pawson; F Chen; I Ernberg
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

Review 5.  Discoidin Domain Receptors: Potential Actors and Targets in Cancer.

Authors:  Hassan Rammal; Charles Saby; Kevin Magnien; Laurence Van-Gulick; Roselyne Garnotel; Emilie Buache; Hassan El Btaouri; Pierre Jeannesson; Hamid Morjani
Journal:  Front Pharmacol       Date:  2016-03-14       Impact factor: 5.810

6.  Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.

Authors:  Yuao Deng; Fang Zhao; Liu Hui; Xiuyun Li; Danyu Zhang; Wang Lin; Zhiqiang Chen; Yingxia Ning
Journal:  J Ovarian Res       Date:  2017-07-25       Impact factor: 4.234

Review 7.  Modes of invasion during tumour dissemination.

Authors:  Pahini Pandya; Jose L Orgaz; Victoria Sanz-Moreno
Journal:  Mol Oncol       Date:  2016-12-09       Impact factor: 6.603

Review 8.  Discoidin domain receptor functions in physiological and pathological conditions.

Authors:  Birgit Leitinger
Journal:  Int Rev Cell Mol Biol       Date:  2014       Impact factor: 6.813

9.  SYK allelic loss and the role of Syk-regulated genes in breast cancer survival.

Authors:  Jan Blancato; Ashley Graves; Banafsheh Rashidi; Maria Moroni; Leopold Tchobe; Metin Ozdemirli; Bhaskar Kallakury; Kepher H Makambi; Catalin Marian; Susette C Mueller
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

10.  Discoidin domain receptor 1 (DDR1) ablation promotes tissue fibrosis and hypoxia to induce aggressive basal-like breast cancers.

Authors:  Ken Takai; Allison P Drain; Devon A Lawson; Laurie E Littlepage; Marcela Karpuj; Kai Kessenbrock; Annie Le; Kenichi Inoue; Valerie M Weaver; Zena Werb
Journal:  Genes Dev       Date:  2018-02-26       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.